Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: Data from an observational study
Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, Teresa A. Simon, Kaleb Michaud
Dive into the research topics of 'Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: Data from an observational study'. Together they form a unique fingerprint.